Twitter used to research misconceptions about illnesses

By Admin
Mark Dredze and Michael Paul, computer scientists at John Hopkins University, collected and assessed 1.5 million tweets, all up to 140 characters in le...

Mark Dredze and Michael Paul, computer scientists at John Hopkins University, collected and assessed 1.5 million tweets, all up to 140 characters in length, posted between May 2009 and October 2010.

Their computer system discarded irrelevant tweets and sorted the data into categories such as flu, allergies, insomnia, cancer and depression.

They then analysed the data to infer how users were treating their illnesses.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

“We found that some people tweeted that they were taking antibiotics for flu. But antibiotics don't work on the flu, which is a virus, and this practice could contribute to the growing antibiotic resistance problems,” said Paul.

“So these tweets showed us that some serious medical misperceptions exist out there.”

They will present their research at the International Conference on Weblogs and Social Media, which is sponsored by the Association for the Advancement of Artificial Intelligence.  

Dredze and Paul have already been in talks with public health scientists, who agree Twitter may be a useful resource for analysing public perceptions of illnesses.

However, as with all social media, Twitter’s use as a research tool is limited.

“In our study we could only learn what people were willing to share,” Paul remarked. “We think there's a limit to what people are willing to share on Twitter.”


Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma